The following policies were recently reviewed for annual update. The full texts of these policies are available in the Provider section of bcbsri.com:
- Absorbable Nasal Implant for Treatment of Nasal Valve Collapse
- Biofeedback
- Biomarker Testing Mandate
- Cryosurgical Ablation of Primary or Metastatic Liver Tumors
- Drug Testing
- Esophageal pH Monitoring
- Focal Treatments for Prostate Cancer
- Genetic Testing for Mitochondrial Disorders
- Ingestible Devices for the Treatment of Constipation
- Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
- Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders
- Islet Transplantation for Chronic Pancreatitis and Donislecel-jujn for Type 1 Diabetes
- Mass Spectrometry (MS) Testing in Monoclonal Gammopathy
- Microwave Tumor Ablation
- Minimally Invasive Procedures for Back Pain
- Noninvasive Techniques for the Evaluation and Monitoring of Patients with Chronic Liver Disease
- Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia and Gastroparesis
- Prolotherapy
- Transcatheter Mitral Valve Repair or Replacement
- Varicose Vein Treatment
- Vertebral Fracture Assessment or Biomechanical Computed Tomography
We also post monthly drafts of medical policies being created or reassessed for your review. As a reminder, you can provide comments on draft policies for up to 30 days. Draft policies are located on the Provider homepage, under the Medical Policies section, under the “Draft Medical Policies” drop-down.